Biotech news
Americas
The Biotechnology Industry Organization has supported potential amendments to the Protect American Talent and Entrepreneurship Act, which was approved by the Senate Judiciary Committee yesterday. 5 June 2015
Asia-Pacific
February’s amendments to the Australian IP Act seek to increase the effectiveness and efficiency of the country’s IP system. LSIPR takes a look at the major changes and considers who will benefit most in the life sciences sector. 21 May 2015
Americas
The University of Oxford has today launched a £300 million project aimed at enhancing the intellectual property of businesses active in the life sciences and medicinal sciences industries. 14 May 2015
Americas
Law firm Burns & Levinson has expanded its intellectual property practice with the hire of life sciences attorneys John Hamilton and Gabriel Goldman. 11 May 2015
Biotech
For companies that are considering conducting patent litigation around the world, the EPO is a very useful forum for testing their strategy or opposition tactics at a relatively low cost. Hazel Ford and Leythem Wall of Finnegan, Henderson, Farabow, Garrett & Dunner describe the numerous advantages of the procedures available. 30 April 2015
Biotech
Biotechnology companies are concerned about the Dutch government’s plans to allow small plant breeders to develop new breeds while avoiding paying licensing fees, according to reports. 23 April 2015
Americas
The US House of Representatives Judiciary Committee will hold a hearing on the Innovation Act tomorrow, during which testaments will be given by representatives from Eli Lilly and the Biotechnology Industry Organization. 13 April 2015
Americas
Patent and trademark attorney firm Murgitroyd has boosted its intellectual property team by promoting Michael Marchant to director. 10 April 2015
Americas
A US hedge fund manager and a company he created has taken aim at Jazz Pharmaceuticals in an inter partes review patent challenge, marking the third time he has challenged a company’s patents. 9 April 2015
Americas
US anti-cancer company Juno Therapeutics and a children’s hospital have settled their patent licensing suit with pharmaceutical business Novartis and the trustees of the University of Pennsylvania. 7 April 2015